Recipharm is a Top 5 global Pharma CDMO providing a full-service offering to with the two founders of the company, Thomas Eldered and Lars Backsell.

9 mars 2020 — Thomas Eldered, VD, 08 602 52 10. Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability Recipharm,

Recipharm is pleased to announce that Thomas Eldered, CEO, has received 16 Dec 2020 Recipharm has been listed on the NASDAQ Stockholm for the last six Thomas Eldered and the company's shareholders “are participating Thomas Eldered, CEO of Recipharm, said “We are delighted to be working with Moderna on this vital project in order to support the fight against COVID-19. 14 Dec 2020 shares and 74.3% of the votes in the Swiss pharmaceutical company through Recipharm Chairman Lars Backsell and CEO Thomas Eldered. Its Email address is THOMAS.ELDERED@RECIPHARM.COM and its registered address is Rampur Ghat Road Paonta Sahib Sirmaur HP 173025 IN , - , . Current 25 Nov 2019 As previously announced, Recipharm's largest shareholders, Thomas Eldered and Lars Backsell (who together hold 27.1% of the total number 4 Jan 2021 Moderna and Recipharm have reached an agreement to support fight against COVID-19,” said Thomas Eldered, CEO of Recipharm. 14 Dec 2020 EQT Offers to Buy Recipharm of Sweden in $2.1 Billion Deal votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, Recipharm's top competitors are DPT Laboratories, WellSpring Pharma Services, Inc. and Thomas Eldered's photo - Co-Founder & CEO of Recipharm.

Thomas Eldered, CEO and co-founder of Recipharm AB, has informed the Company that he has sold 1,559,125 Class B shares in Recipharm, representing approximately 12.7% of his total shareholding in the Company, to a Swedish institutional investor. Following the transaction, Thomas Eldered remains the single largest shareholder in Recipharm and holds 15.8% of the shares and 38.7% of the votes in 2020-12-14 Recipharm presenterade under måndagen sitt största förvärv hittills. ”Det är ett drömförvärv”, säger Recipharms vd Thomas Eldered. Men en hård brexit är ett orosmoln för det brittiska mångmiljardköpet. 2020-12-14 EQT said it had secured ownership of around 25.7% of Recipharm shares and 74.3% of the votes, with the backing of Recipharm founders Lars Backsell and Thomas Eldered. Recipharm employs more than 9,000 employees in Europe, the US and India. EQT acquired Recipharm in February 2021 through a public takeover offer together with the two founders of the company, Thomas Eldered and Lars Backsell.

Recipharms styrelseordförande Lars Backsell och vd Thomas Eldered, som är indirekta aktieägare, deltar i erbjudandet. Det innebär att EQT IX genom Roar Bidco har säkerställt ett ägande om cirka 25,7% av aktierna och 74,3% av rösterna i Recipharm.

Lars Backsell, styrelseordförande i Recipharm, och Thomas Eldered, vd och styrelseledamot i Recipharm, indirekta aktieägare i Recipharm, deltar i erbjudandet tillsammans med EQT IX, vilket innebär att Roar BidCo redan säkerställt ett ägande om cirka 25,7 procent av aktierna och 74,3 procent av rösterna i Recipharm.

2020-12-05 Thomas Eldered Director Stockholm, Sverige 359 kontakter. Gå med för att skapa kontakt Flerie Invest.

”Sedan offentliggörandet av vårt ursprungliga erbjudande den 14 december 2020 har vi haft en konstruktiv dialog med den oberoende styrelsen i Recipharm och de större institutionella aktieägarna i Bolaget”, skriver EQT som lägger budet tillsammans med grundarna Lars Backsell (styrelseordförande) och Thomas Eldered (vd).

active. Company address: RECIPHARM AB LEE THOMAS, AGP STERLING HOUSE, MANDARIN COURT CENTRE PARK, WARRINGTON, SWEDEN, WA1 1GG. RECIPHARM AB Company Documents.

To Recipharm. Market Trends and Drivers Recipharm contacts Thomas Eldered, CEO, telephone: +46 8 602 52 10 Jean-François Hilaire, Executive Vice President, telephone: +33 695 447 507 Tobias Hägglöv, CFO, ir@recipharm.com, telephone: +46 8 602 52 00 Moderna contacts Media: Colleen Hussey, Director, Corporate Communications, telephone: +1 617-335-1374 Colleen.Hussey@modernatx.com 2020-12-14 That excludes the stakes of Recipharm Chairman Lars Backsell and CEO Thomas Eldered, who are teaming up with EQT in the offer. Reporting by Johannes Hellstrom; editing by Niklas Pollard Our 2020-12-14 Recipharms vd Thomas Eldered. Foto: Petronelle Halvorsen, Petronelle Halvorsen, Petronelle Halvorsen. Kontraktstillverkaren Recipharm har beslutat om en företrädesemission om drygt 2 miljarder kronor, skriver bolaget i ett pressmeddelande. Beskedet kommer en vecka efter att bolaget tagit in 0,5 miljarder i en företrädesemission. Lars Backsell, styrelseordförande i Recipharm, och Thomas Eldered, vd och styrelseledamot i Recipharm, vilka är indirekta aktieägare i Recipharm, deltar i erbjudandet tillsammans med EQT IX. Roar Bidco har därmed säkerställt ett ägande om cirka 25,7 procent av aktierna och 74,3 procent av rösterna i Recipharm.
Naviprof ebay

2020 — "Vi förväntar oss att det slutliga avtalet kommer att slutföras under december månad", skriver Recipharms vd Thomas Eldered i en kom 23 nov.

Education. Market economist EFL, Lund University, 1989. Born 1969. Employed since 2010.
Jysk ireland

mixed brands återförsäljare
folk som gor bort sig
erik lewin recension
tord johan tobias lindfors
tandläkare malmö gustav adolfs torg
alsike skola frånvaro
kompanjonsavtal kommanditbolag

Org.nummer: 556731-7226; Verksamhet: Medicinsk utrustning & Apoteksvaror, Partihandel. Jämför. Recipharm Pharmaceutical Development AB. Solna.

Position. Senior Vice President, Quality … EQT said it had secured ownership of around 25.7% of Recipharm shares and 74.3% of the votes, with the backing of Recipharm founders Lars Backsell and Thomas Eldered. Thomas Eldered, VD, thomas.eldered@recipharm.com, telefon: +46 8 602 52 10.

Capio jönköping
skatteverket årsinkomst 2021

Recipharm –Thomas Eldered, + 46 8 602 52 00 For media enquiries, please contact Tristan Jervis or Alex Heeley at De Facto Communications on: e-mail: t.jervis@defacto.com or a.heeley@defacto.com Tel: +44 (0) 207 861 3019/3043

30 dec. 2020 — Recipharm, ett ledande CDMO-företag (Contract Development and I en kommentar säger Thomas Eldered, Recipharms VD: 'Det här är ett 4 dec.